Android app Apple app link

Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare

By Yahoo! Finance   |   1 month ago
Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare

Conestoga Capital Advisors' first-quarter 2025 investor letter discusses market trends and performance, highlighting Repligen Corporation (NASDAQ:RGEN) as a key stock pick. Despite market volatility, RGEN's bioprocessing technologies show potential for growth according to the company's analysis.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.